Geode Capital Management, LLC Amicus Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 6,599,871 shares of FOLD stock, worth $63.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,599,871

Previous 6,518,945 1.24%

Holding current value

$63.9 Million

Previous $64.7 Million 9.0%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$9.55 - $12.09 $772,843 - $978,395	80,926 Added 1.24%	6,599,871 $70.5 Million
Q2 2024 Aug 09, 2024	BUY	$9.04 - $11.75 $2.79 Million - $3.62 Million	308,209 Added 4.96%	6,518,945 $64.7 Million
Q1 2024 May 13, 2024	BUY	$11.43 - $14.24 $2.97 Million - $3.69 Million	259,441 Added 4.36%	6,210,736 $73.2 Million
Q4 2023 Feb 13, 2024	BUY	$9.97 - $14.52 $3.44 Million - $5.01 Million	345,129 Added 6.16%	5,951,295 $84.4 Million
Q3 2023 Nov 13, 2023	BUY	$11.78 - $13.86 $2.48 Million - $2.92 Million	210,560 Added 3.9%	5,606,166 $68.2 Million
Q2 2023 Aug 11, 2023	BUY	$10.72 - $13.3 $2.71 Million - $3.37 Million	253,199 Added 4.92%	5,395,606 $67.8 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $2.75 Million - $3.41 Million	251,979 Added 5.15%	5,142,407 $57 Million
Q4 2022 Feb 13, 2023	BUY	$9.89 - $12.7 $1.66 Million - $2.13 Million	167,542 Added 3.55%	4,890,428 $59.7 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $624,866 - $811,308	63,632 Added 1.37%	4,722,886 $49.3 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $11.12 $890,908 - $1.59 Million	143,003 Added 3.17%	4,659,254 $50 Million
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $1.66 Million - $2.63 Million	-210,482 Reduced 4.45%	4,516,251 $42.8 Million
Q4 2021 Feb 11, 2022	BUY	$9.82 - $12.44 $2.71 Million - $3.43 Million	275,911 Added 6.2%	4,726,733 $54.6 Million
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $1.71 Million - $2.31 Million	-195,109 Reduced 4.2%	4,450,822 $42.5 Million
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $2.36 Million - $2.9 Million	270,704 Added 6.19%	4,645,931 $44.8 Million
Q1 2021 May 12, 2021	BUY	$9.2 - $23.86 $2.91 Million - $7.54 Million	316,124 Added 7.79%	4,375,227 $43.2 Million
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $2.95 Million - $5.45 Million	219,012 Added 5.7%	4,059,103 $93.7 Million
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $429,224 - $529,121	-33,299 Reduced 0.86%	3,840,091 $54.2 Million
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $563,097 - $997,177	63,555 Added 1.67%	3,873,390 $58.4 Million
Q1 2020 May 14, 2020	BUY	$6.63 - $11.16 $2.01 Million - $3.39 Million	303,764 Added 8.66%	3,809,835 $35.2 Million
Q4 2019 Feb 13, 2020	BUY	$7.48 - $10.75 $1.1 Million - $1.58 Million	146,857 Added 4.37%	3,506,071 $34.1 Million
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $1.47 Million - $2.42 Million	182,723 Added 5.75%	3,359,214 $26.9 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $4.96 Million - $6.51 Million	452,284 Added 16.6%	3,176,491 $39.6 Million
Q1 2019 May 14, 2019	BUY	$10.04 - $13.92 $5.43 Million - $7.52 Million	540,528 Added 24.75%	2,724,207 $37 Million
Q4 2018 Feb 13, 2019	BUY	$8.38 - $13.44 $1.52 Million - $2.43 Million	180,938 Added 9.03%	2,183,679 $20.9 Million
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $943,068 - $1.34 Million	81,299 Added 4.23%	2,002,741 $24.2 Million
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $2.36 Million - $3.07 Million	179,629 Added 10.31%	1,921,442 $30 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $2.42 Million - $3.01 Million	175,552 Added 11.21%	1,741,813 $26.2 Million
Q4 2017 Feb 13, 2018	BUY	$12.51 - $16.24 $1.17 Million - $1.51 Million	93,172 Added 6.32%	1,566,261 $22.5 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $2.61 Million - $3.5 Million	222,064 Added 17.75%	1,473,089 $22.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,251,025	1,251,025 $12.6 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.72B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Amicus Therapeutics, Inc. Transaction History